These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 9269994)

  • 1. A BRCA1 mutant alters G2-M cell cycle control in human mammary epithelial cells.
    Larson JS; Tonkinson JL; Lai MT
    Cancer Res; 1997 Aug; 57(16):3351-5. PubMed ID: 9269994
    [TBL] [Abstract][Full Text] [Related]  

  • 2. BRCA1 activates a G2-M cell cycle checkpoint following 6-thioguanine-induced DNA mismatch damage.
    Yamane K; Schupp JE; Kinsella TJ
    Cancer Res; 2007 Jul; 67(13):6286-92. PubMed ID: 17616687
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effects of lovastatin on cell cycle distribution in MCF-7 cells transfected with BRCA1].
    Luo YQ; Mi MT; Wei N; Xu HX; Zhu JD
    Ai Zheng; 2004 Aug; 23(8):924-8. PubMed ID: 15301716
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Gadd45 mediated G2/M cell cycle arrest induced by BRCA1].
    Song YM; Tong T; Fu M; Dong LJ; Jin SQ; Wu M; Zhan QM
    Ai Zheng; 2004 May; 23(5):517-21. PubMed ID: 15142446
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of an amino-terminal BRCA1 deletion mutant causes a dominant growth inhibition in MCF10A cells.
    You F; Chiba N; Ishioka C; Parvin JD
    Oncogene; 2004 Jul; 23(34):5792-8. PubMed ID: 15122325
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overexpression of a protein fragment of RNA helicase A causes inhibition of endogenous BRCA1 function and defects in ploidy and cytokinesis in mammary epithelial cells.
    Schlegel BP; Starita LM; Parvin JD
    Oncogene; 2003 Feb; 22(7):983-91. PubMed ID: 12592385
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of BRCA1 in breast cell lines causes the centrosome duplication cycle to be disconnected from the cell cycle.
    Ko MJ; Murata K; Hwang DS; Parvin JD
    Oncogene; 2006 Jan; 25(2):298-303. PubMed ID: 16170356
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Construction and characterization of recombinant adenoviruses expressing human BRCA1 or murine Brca1 genes.
    Campbell M; Aprelikova ON; van der Meer R; Woltjer RL; Yee CJ; Liu ET; Jensen RA
    Cancer Gene Ther; 2001 Mar; 8(3):231-9. PubMed ID: 11332994
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in BRCA2 expression during progression of the cell cycle.
    Wang SC; Lin SH; Su LK; Hung MC
    Biochem Biophys Res Commun; 1997 May; 234(1):247-51. PubMed ID: 9168997
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cell cycle regulation of BRCA1 messenger RNA in human breast epithelial cells.
    Gudas JM; Li T; Nguyen H; Jensen D; Rauscher FJ; Cowan KH
    Cell Growth Differ; 1996 Jun; 7(6):717-23. PubMed ID: 8780885
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence for a second cell cycle block at G2/M by p53.
    Stewart N; Hicks GG; Paraskevas F; Mowat M
    Oncogene; 1995 Jan; 10(1):109-15. PubMed ID: 7529916
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of BRCA1 and BRCA2 expression in human breast cancer cells by DNA-damaging agents.
    Andres JL; Fan S; Turkel GJ; Wang JA; Twu NF; Yuan RQ; Lamszus K; Goldberg ID; Rosen EM
    Oncogene; 1998 Apr; 16(17):2229-41. PubMed ID: 9619832
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autographa californica nucleopolyhedrovirus infection results in Sf9 cell cycle arrest at G2/M phase.
    Braunagel SC; Parr R; Belyavskyi M; Summers MD
    Virology; 1998 Apr; 244(1):195-211. PubMed ID: 9581791
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidermal growth factor-dependent cell cycle progression is altered in mammary epithelial cells that overexpress c-myc.
    Nass SJ; Dickson RB
    Clin Cancer Res; 1998 Jul; 4(7):1813-22. PubMed ID: 9676860
    [TBL] [Abstract][Full Text] [Related]  

  • 15. BRCA1 expression is induced before DNA synthesis in both normal and tumor-derived breast cells.
    Vaughn JP; Davis PL; Jarboe MD; Huper G; Evans AC; Wiseman RW; Berchuck A; Iglehart JD; Futreal PA; Marks JR
    Cell Growth Differ; 1996 Jun; 7(6):711-5. PubMed ID: 8780884
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Direct interaction between BRCA1 and the estrogen receptor regulates vascular endothelial growth factor (VEGF) transcription and secretion in breast cancer cells.
    Kawai H; Li H; Chun P; Avraham S; Avraham HK
    Oncogene; 2002 Oct; 21(50):7730-9. PubMed ID: 12400015
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The BRCT domain is a phospho-protein binding domain.
    Yu X; Chini CC; He M; Mer G; Chen J
    Science; 2003 Oct; 302(5645):639-42. PubMed ID: 14576433
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of phosphorylation on BRCA1 during the cell cycle and after DNA damage.
    Thomas JE; Smith M; Tonkinson JL; Rubinfeld B; Polakis P
    Cell Growth Differ; 1997 Jul; 8(7):801-9. PubMed ID: 9218874
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression profiles of BRCA1 splice variants in asynchronous and in G1/S synchronized tumor cell lines.
    Orban TI; Olah E
    Biochem Biophys Res Commun; 2001 Jan; 280(1):32-8. PubMed ID: 11162473
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BRCA1 carries tumor suppressor activity distinct from that of p53 and p21.
    Randrianarison V; Marot D; Foray N; Cabannes J; Méret V; Connault E; Vitrat N; Opolon P; Perricaudet M; Feunteun J
    Cancer Gene Ther; 2001 Oct; 8(10):759-70. PubMed ID: 11687899
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.